|
MITD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.64579485992545E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.04350014477006E-10 |
| Normal-vs-Stage2 |
8.428000E-04 |
| Normal-vs-Stage3 |
1.955740E-03 |
| Normal-vs-Stage4 |
1.778290E-02 |
| Stage1-vs-Stage2 |
4.277200E-01 |
| Stage1-vs-Stage3 |
4.926200E-01 |
| Stage1-vs-Stage4 |
2.245200E-01 |
| Stage2-vs-Stage3 |
3.521800E-01 |
| Stage2-vs-Stage4 |
3.089000E-01 |
| Stage3-vs-Stage4 |
1.732970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.43829947951701E-10 |
| Normal-vs-AfricanAmerican |
2.3219000055974E-09 |
| Normal-vs-Asian |
9.808400E-02 |
| Caucasian-vs-AfricanAmerican |
3.499400E-01 |
| Caucasian-vs-Asian |
5.399200E-01 |
| AfricanAmerican-vs-Asian |
7.797800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04250053034605E-10 |
| Normal-vs-Female |
5.49279999262353E-09 |
| Male-vs-Female |
5.857200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.30119999999889E-05 |
| Normal-vs-Extreme_Weight |
6.72719990824078E-10 |
| Normal-vs-Obese |
1.67960000019285E-07 |
| Normal-vs-Extreme_Obese |
4.550800E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.928200E-01 |
| Normal_Weight-vs-Obese |
8.573600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.877600E-01 |
| Extreme_Weight-vs-Obese |
4.821200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.794600E-01 |
| Obese-vs-Extreme_Obese |
7.425800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.766100E-04 |
| Normal-vs-Age(41-60Yrs) |
6.73616717961067E-12 |
| Normal-vs-Age(61-80Yrs) |
1.22279999459352E-08 |
| Normal-vs-Age(81-100Yrs) |
6.678600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.738800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.538400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.623800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.400400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.989800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.817000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.00204305858642E-13 |
| Normal-VS-Type2 PRCC |
1.846250E-04 |
| Normal-VS-KIRP CIMP |
6.490300E-02 |
| Normal-VS-Unclassified PRCC |
8.27079999999869E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.996000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.576240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.049600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.622800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.104200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.856600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.51579999999996E-05 |
| Normal-vs-N1 |
5.010900E-04 |
| Normal-vs-N2 |
3.064400E-01 |
| N0-vs-N1 |
1.506580E-01 |
| N0-vs-N2 |
6.484800E-01 |
| N1-vs-N2 |
9.635600E-01 |
|
|
